Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside–based low-intensity therapy
暂无分享,去创建一个
M. Konopleva | G. Garcia-Manero | T. Kadia | F. Ravandi | G. Borthakur | N. Daver | C. Dinardo | N. Pemmaraju | N. Short | H. Abbas | S. Venugopal